197 related articles for article (PubMed ID: 37017901)
1. Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis.
Almarjan AI; Almarjan SA; Masoud AT
High Blood Press Cardiovasc Prev; 2023 May; 30(3):207-218. PubMed ID: 37017901
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Sacubitril/Valsartan (LCZ696) Compared With Olmesartan in Elderly Asian Patients (≥65 Years) With Systolic Hypertension.
Supasyndh O; Wang J; Hafeez K; Zhang Y; Zhang J; Rakugi H
Am J Hypertens; 2017 Nov; 30(12):1163-1169. PubMed ID: 28992296
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study.
Rakugi H; Kario K; Yamaguchi M; Sasajima T; Gotou H; Zhang J
Hypertens Res; 2022 May; 45(5):824-833. PubMed ID: 35058583
[TBL] [Abstract][Full Text] [Related]
4. Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension.
Zhang Y; Zhao X; Huang H; Li M
Clin Res Cardiol; 2023 Jul; 112(7):855-867. PubMed ID: 36326841
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double-blind, 8-week study.
Huo Y; Li W; Webb R; Zhao L; Wang Q; Guo W
J Clin Hypertens (Greenwich); 2019 Jan; 21(1):67-76. PubMed ID: 30536595
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive Effects of Sacubitril/Valsartan Versus Olmesartan: An Updated Systemic Review and Meta-Analysis of Randomized Controlled Trials.
Raja R; Kumari S; Umer Khan M; Ayaz A; Jaffar D; Mohamad Z; Muzammil MA; Sohail N; Ahmed Qureshi S; Saeed H; Fahad Amin M; Jawad A; Varrassi G; Kumar S; Khatri M; Maryam A
Cureus; 2023 Nov; 15(11):e48692. PubMed ID: 38090459
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effect of sacubitril/valsartan: a meta-analysis.
De Vecchis R; Ariano C; Soreca S
Minerva Cardioangiol; 2019 Jun; 67(3):214-222. PubMed ID: 30895762
[TBL] [Abstract][Full Text] [Related]
8. Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study.
Williams B; Cockcroft JR; Kario K; Zappe DH; Brunel PC; Wang Q; Guo W
Hypertension; 2017 Mar; 69(3):411-420. PubMed ID: 28093466
[TBL] [Abstract][Full Text] [Related]
9. Long-term (52-week) safety and efficacy of Sacubitril/valsartan in Asian patients with hypertension.
Supasyndh O; Sun N; Kario K; Hafeez K; Zhang J
Hypertens Res; 2017 May; 40(5):472-476. PubMed ID: 27853163
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study.
Cheung DG; Aizenberg D; Gorbunov V; Hafeez K; Chen CW; Zhang J
J Clin Hypertens (Greenwich); 2018 Jan; 20(1):150-158. PubMed ID: 29338113
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sacubitril/valsartan in the treatment of middle-aged and elderly patients with hypertension: a systematic review and meta-analysis of randomized controlled trials.
Wu HX; Liu KK; Li BN; Liu S; Jin JC
Ann Palliat Med; 2022 May; 11(5):1811-1825. PubMed ID: 35672897
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Crystalline Valsartan/Sacubitril (LCZ696) Compared With Placebo and Combinations of Free Valsartan and Sacubitril in Patients With Systolic Hypertension: The RATIO Study.
Izzo JL; Zappe DH; Jia Y; Hafeez K; Zhang J
J Cardiovasc Pharmacol; 2017 Jun; 69(6):374-381. PubMed ID: 28338503
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety Comparative of Sacubitril/Valsartan vs. Olmesartan in the Treatment of hypertension: A Meta-analysis of RCTs.
Han Y; Zhou Y; Na J; Li F; Sun Y
Am J Hypertens; 2023 Nov; 36(12):643-650. PubMed ID: 37596996
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sacubitril/valsartan with olmesartan for hypertension: A meta-analysis of randomized controlled trials.
Sun Y; Yang H
Medicine (Baltimore); 2024 Apr; 103(14):e37501. PubMed ID: 38579097
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of LCZ696 for Short-term Management of Essential Hypertension Compared With ARBs: A Meta-analysis of Randomized Controlled Trials.
Yang S; Zhang H; Yang P; Wang C; Wu Q
J Cardiovasc Pharmacol; 2021 May; 77(5):650-659. PubMed ID: 33951700
[TBL] [Abstract][Full Text] [Related]
16. Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Multicenter Study.
Kario K; Rakugi H; Yarimizu D; Morita Y; Eguchi S; Iekushi K
J Am Heart Assoc; 2023 Apr; 12(8):e027612. PubMed ID: 37026551
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Sacubitril/Valsartan in Hypertension.
Malik AH; Aronow WS
Am J Ther; 2022 May-Jun 01; 29(3):e322-e333. PubMed ID: 30664018
[TBL] [Abstract][Full Text] [Related]
18. The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
Schmieder RE; Wagner F; Mayr M; Delles C; Ott C; Keicher C; Hrabak-Paar M; Heye T; Aichner S; Khder Y; Yates D; Albrecht D; Langenickel T; Freyhardt P; Janka R; Bremerich J
Eur Heart J; 2017 Nov; 38(44):3308-3317. PubMed ID: 29029087
[TBL] [Abstract][Full Text] [Related]
19. Anti-Hypertensive Effect of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials.
De Vecchis R; Soreca S; Ariano C
Cardiol Res; 2019 Feb; 10(1):24-33. PubMed ID: 30834056
[TBL] [Abstract][Full Text] [Related]
20. Effects of LCZ696 (Sacubitril/Valsartan) on Blood Pressure in Patients with Hypertension: A Meta-Analysis of Randomized Controlled Trials.
Geng Q; Yan R; Wang Z; Hou F
Cardiology; 2020; 145(9):589-598. PubMed ID: 32726791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
